Renal gene and protein expression signatures for prediction of kidney disease progression.
暂无分享,去创建一个
C. Stoeckert | S. McWeeney | K. Shedden | W. Ju | Felix Eichinger | M. Bitzer | C. Cohen | M. Kretzler | S. Dikman | J. Kopp | E. Böttinger | C. Berthier | B. Schröppel | D. Schlondorff | A. Henger | David B. Thomas | S. Krick | Jun Oh | J. Oh | Felix H. Eichinger
[1] I. Higuchi. [Collagen VI-related muscle disorders]. , 2011, Brain and nerve = Shinkei kenkyu no shinpo.
[2] Lajos Pusztai,et al. Gene expression profiling of breast cancer , 2009, Breast Cancer Research.
[3] W. Ju,et al. Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease , 2008, Proceedings of the National Academy of Sciences.
[4] B. Brenner,et al. Renal risk scores: progress and prospects. , 2008, Kidney international.
[5] T. Hostetter,et al. Staging of chronic kidney disease: time for a course correction. , 2008, Journal of the American Society of Nephrology : JASN.
[6] S. Paik,et al. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase‐3 activity in Hep3B cells , 2008, Journal of cellular biochemistry.
[7] Jian Yu,et al. Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung cancer , 2008 .
[8] Jian Yu,et al. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. , 2008, Carcinogenesis.
[9] C. Niehrs,et al. Dkk3 is required for TGF‐β signaling during Xenopus mesoderm induction , 2007 .
[10] C. Heizmann,et al. S100B and S100A6 Differentially Modulate Cell Survival by Interacting with Distinct RAGE (Receptor for Advanced Glycation End Products) Immunoglobulin Domains* , 2007, Journal of Biological Chemistry.
[11] S. Chadban,et al. TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.
[12] Arnoldo Frigessi,et al. BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm305 Gene expression Predicting survival from microarray data—a comparative study , 2022 .
[13] E. Bottinger. TGF-β in renal injury and disease , 2007 .
[14] B. Freedman,et al. Familial Clustering of Chronic Kidney Disease , 2007, Seminars in dialysis.
[15] H. Dressman,et al. Gene Expression Signatures That Predict Radiation Exposure in Mice and Humans , 2007, PLoS medicine.
[16] E. Böttinger. TGF-beta in renal injury and disease. , 2007, Seminars in nephrology.
[17] C. Niehrs,et al. Dkk3 is required for TGF-beta signaling during Xenopus mesoderm induction. , 2007, Differentiation; research in biological diversity.
[18] R. Schwabe,et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. , 2007, Nature medicine.
[19] Tanja Popovic,et al. Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. , 2007, MMWR. Morbidity and mortality weekly report.
[20] B. Brenner,et al. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. , 2006, Kidney international.
[21] Felix Eichinger,et al. Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.
[22] R. Lu,et al. Luman/CREB3 Induces Transcription of the Endoplasmic Reticulum (ER) Stress Response Protein Herp through an ER Stress Response Element , 2006, Molecular and Cellular Biology.
[23] C. Langefeld,et al. Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. , 2006, Hypertension.
[24] C. Cohen,et al. Gene expression profiling analysis in nephrology: towards molecular definition of renal disease , 2006, Clinical and Experimental Nephrology.
[25] R. Kucherlapati,et al. Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation , 2006, Molecular and Cellular Biology.
[26] Youhua Liu,et al. Renal fibrosis: new insights into the pathogenesis and therapeutics. , 2006, Kidney international.
[27] Wei-Hwa Lee,et al. Calcium-binding proteins annexin A2 and S100A6 are sensors of tubular injury and recovery in acute renal failure. , 2005, Kidney international.
[28] S. Snyder,et al. Detection and evaluation of chronic kidney disease. , 2005, American family physician.
[29] Giuseppe Remuzzi,et al. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. , 2005, Kidney international. Supplement.
[30] T. Kita,et al. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. , 2005, Kidney international.
[31] W. Scott,et al. The TGF‐β1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes , 2005 .
[32] W. Scott,et al. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. , 2005, Diabetic Medicine.
[33] A. Shaw,et al. A Novel Role for the Adaptor Molecule CD2-associated Protein in Transforming Growth Factor-β-induced Apoptosis* , 2004, Journal of Biological Chemistry.
[34] Paul Marjoram,et al. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus , 2004, Oncogene.
[35] C. Cohen,et al. Gene expression analysis in renal biopsies. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] M. Suthanthiran,et al. Transforming growth factor beta and progression of renal disease. , 2003, Kidney international. Supplement.
[37] R. Kucherlapati,et al. Hierarchical model of gene regulation by transforming growth factor β , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] X. Wang,et al. Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.
[39] A I Saeed,et al. TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.
[40] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[41] D. Salant,et al. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. , 2002, The Journal of clinical investigation.
[42] J. Zavadil,et al. Applications for Microarrays in Renal Biology and Medicine , 2002, Nephron Experimental Nephrology.
[43] Ethan M Balk,et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[44] G. Bakris,et al. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease , 2002, Vascular medicine.
[45] K Doqi,et al. clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .
[46] C. Cohen,et al. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. , 2002, Kidney international.
[47] E. Bottinger,et al. Apoptosis in podocytes induced by TGF-β and Smad7 , 2001 .
[48] M K Kerr,et al. Bootstrapping cluster analysis: Assessing the reliability of conclusions from microarray experiments , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Bitzer,et al. Apoptosis in podocytes induced by TGF-beta and Smad7. , 2001, The Journal of clinical investigation.
[50] Arthur E. Hoerl,et al. Ridge Regression: Biased Estimation for Nonorthogonal Problems , 2000, Technometrics.
[51] E. Bottinger,et al. A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.
[52] M. Bitzer,et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. , 2000, Genes & development.
[53] Jeffrey B. Kopp,et al. TGF- and fibrosis , 1999 .
[54] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[55] M. Bitzer,et al. Transforming Growth Factor-β in Renal Disease , 1998, Kidney and Blood Pressure Research.
[56] M. Bitzer,et al. Transforming growth factor-beta in renal disease. , 1998, Kidney & blood pressure research.
[57] B. Padanilam,et al. Induction of calcyclin after ischemic injury to rat kidney. , 1997, The American journal of physiology.
[58] S. Thorgeirsson,et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[59] M. Sporn,et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[60] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[61] W. Border,et al. Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.
[62] R. Jaenisch,et al. Transgenic mouse model of kidney disease: Insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome , 1990, Cell.
[63] E. Lewis,et al. The importance of sample size in the interpretation of the renal biopsy. , 1988, American journal of nephrology.